EEF1D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.719200E-01
Normal-vs-Stage2
9.494400E-01
Normal-vs-Stage3
4.227200E-01
Normal-vs-Stage4
6.641000E-01
Stage1-vs-Stage2
6.009200E-01
Stage1-vs-Stage3
6.753000E-01
Stage1-vs-Stage4
9.382200E-01
Stage2-vs-Stage3
2.949600E-01
Stage2-vs-Stage4
9.767600E-02
Stage3-vs-Stage4
5.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.066200E-01
Normal-vs-AfricanAmerican
5.373800E-01
Normal-vs-Asian
9.468800E-01
Caucasian-vs-AfricanAmerican
4.448300E-02
Caucasian-vs-Asian
7.995800E-01
AfricanAmerican-vs-Asian
3.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.807800E-01
Normal-vs-Female
7.657400E-01
Male-vs-Female
3.211200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.286800E-01
Normal-vs-Age(41-60Yrs)
8.790800E-01
Normal-vs-Age(61-80Yrs)
8.190400E-01
Normal-vs-Age(81-100Yrs)
5.010600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.922400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.525600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.032790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.512600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.573500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.854200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.811000E-01
Normal-vs-Daily Drinker
7.410000E-01
Normal-vs-Weekly Drinker
9.399600E-01
Normal-vs-Occasional Drinker
9.761600E-01
Normal-vs-Social Drinker
7.990400E-01
Non Drinker-vs-Daily Drinker
2.767000E-01
Non Drinker-vs-Weekly Drinker
7.329800E-01
Non Drinker-vs-Occasional Drinker
8.182200E-01
Non Drinker-vs-Social Drinker
7.303200E-01
Daily Drinker-vs-Weekly Drinker
7.343200E-01
Daily Drinker-vs-Occasional Drinker
4.686800E-01
Daily Drinker-vs-Social Drinker
2.845400E-01
Weekly Drinker-vs-Occasional Drinker
8.402000E-01
Weekly Drinker-vs-Social Drinker
5.960400E-01
Occasional Drinker-vs-Social Drinker
6.270000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.018000E-01
Normal-vs-Grade 2
9.732800E-01
Normal-vs-Grade 3
7.891600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.979200E-01
Grade 1-vs-Grade 3
1.093640E-01
Grade 1-vs-Grade 4
8.018000E-01
Grade 2-vs-Grade 3
1.958780E-01
Grade 2-vs-Grade 4
9.732800E-01
Grade 3-vs-Grade 4
7.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.980800E-01
Normal-vs-NonDiabetic
9.640000E-01
Diabetic-vs-NonDiabetic
6.158600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.890200E-01
Normal-vs-NoPancreatitis
9.354000E-01
Pancreatitis-vs-NoPancreatitis
1.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.340200E-01
Normal-vs-N1
9.139400E-01
N0-vs-N1
9.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.849800E-01
Normal-vs-TP53-NonMutant
5.645000E-01
TP53-Mutant-vs-TP53-NonMutant
4.443800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
